TCRX logo

TScan Therapeutics (TCRX) Operating Profit

Annual Operating Profit

-$93.46 M
-$26.82 M-40.25%

December 31, 2023


Summary


Performance

TCRX Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTCRXprofitabilitymetrics:

Quarterly Operating Profit

-$32.62 M
+$1.49 M+4.37%

September 30, 2024


Summary


Performance

TCRX Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTCRXprofitabilitymetrics:

TTM Operating Profit

-$119.47 M
-$7.87 M-7.06%

September 30, 2024


Summary


Performance

TCRX TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTCRXprofitabilitymetrics:

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

TCRX Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-40.3%-31.8%-31.6%
3 y3 years-256.3%-31.8%-31.6%
5 y5 years-557.7%-31.8%-31.6%

TCRX Operating Profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-92.1%at low-129.7%+4.4%-145.6%at low
5 y5-year-557.7%at low-480.9%+4.4%-2019.7%at low
alltimeall time-557.7%at low-480.9%+4.4%-2019.7%at low

TScan Therapeutics Operating Profit History

DateAnnualQuarterlyTTM
Sep 2024
-
-$32.62 M(-4.4%)
-$119.47 M(+7.1%)
Jun 2024
-
-$34.11 M(+8.7%)
-$111.59 M(+9.3%)
Mar 2024
-
-$31.37 M(+46.9%)
-$102.09 M(+9.2%)
Dec 2023
-$93.46 M(+40.3%)
-$21.36 M(-13.7%)
-$93.46 M(+3.0%)
Sep 2023
-
-$24.75 M(+0.6%)
-$90.75 M(+9.9%)
Jun 2023
-
-$24.61 M(+8.2%)
-$82.58 M(+12.8%)
Mar 2023
-
-$22.74 M(+22.0%)
-$73.22 M(+9.9%)
Dec 2022
-$66.64 M
-$18.65 M(+12.5%)
-$66.64 M(+7.2%)
Sep 2022
-
-$16.58 M(+8.7%)
-$62.19 M(+1.2%)
Jun 2022
-
-$15.25 M(-5.7%)
-$61.45 M(+8.0%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$16.16 M(+13.8%)
-$56.89 M(+17.0%)
Dec 2021
-$48.64 M(+85.4%)
-$14.20 M(-10.4%)
-$48.64 M(+15.1%)
Sep 2021
-
-$15.84 M(+48.3%)
-$42.25 M(+25.8%)
Jun 2021
-
-$10.68 M(+34.9%)
-$33.58 M(+17.8%)
Mar 2021
-
-$7.92 M(+1.4%)
-$28.52 M(+8.7%)
Dec 2020
-$26.23 M(+84.6%)
-
-
Dec 2020
-
-$7.81 M(+8.9%)
-$26.23 M(+42.4%)
Sep 2020
-
-$7.17 M(+27.7%)
-$18.42 M(+63.7%)
Jun 2020
-
-$5.62 M(-0.4%)
-$11.25 M(+99.6%)
Mar 2020
-
-$5.64 M
-$5.64 M
Dec 2019
-$14.21 M
-
-

FAQ

  • What is TScan Therapeutics annual operating income?
  • What is the all time high annual operating profit for TScan Therapeutics?
  • What is TScan Therapeutics annual operating profit year-on-year change?
  • What is TScan Therapeutics quarterly operating income?
  • What is the all time high quarterly operating profit for TScan Therapeutics?
  • What is TScan Therapeutics quarterly operating profit year-on-year change?
  • What is TScan Therapeutics TTM operating income?
  • What is the all time high TTM operating profit for TScan Therapeutics?
  • What is TScan Therapeutics TTM operating profit year-on-year change?

What is TScan Therapeutics annual operating income?

The current annual operating profit of TCRX is -$93.46 M

What is the all time high annual operating profit for TScan Therapeutics?

TScan Therapeutics all-time high annual operating income is -$14.21 M

What is TScan Therapeutics annual operating profit year-on-year change?

Over the past year, TCRX annual operating income has changed by -$26.82 M (-40.25%)

What is TScan Therapeutics quarterly operating income?

The current quarterly operating profit of TCRX is -$32.62 M

What is the all time high quarterly operating profit for TScan Therapeutics?

TScan Therapeutics all-time high quarterly operating income is -$5.62 M

What is TScan Therapeutics quarterly operating profit year-on-year change?

Over the past year, TCRX quarterly operating income has changed by -$7.87 M (-31.82%)

What is TScan Therapeutics TTM operating income?

The current TTM operating profit of TCRX is -$119.47 M

What is the all time high TTM operating profit for TScan Therapeutics?

TScan Therapeutics all-time high TTM operating income is -$5.64 M

What is TScan Therapeutics TTM operating profit year-on-year change?

Over the past year, TCRX TTM operating income has changed by -$28.72 M (-31.64%)